1. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation. Issue 11 (November 2020) Authors: Prat, Aleix; Guarneri, Valentina; Paré, Laia; Griguolo, Gaia; Pascual, Tomás; Dieci, Maria V; Chic, Núria; González-Farré, Blanca; Frassoldati, Antonio; Sanfeliu, Esther; Cejalvo, Juan M; Muñoz, Montserrat; Bisagni, Giancarlo; Brasó-Maristany, Fara; Urso, Loredana; Vidal, Maria; Brandes, Alba A; ... Journal: Lancet oncology Issue: Volume 21:Issue 11(2020) Page Start: 1455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical implications of the intrinsic molecular subtypes of breast cancer. (1st November 2015) Authors: Prat, Aleix; Pineda, Estela; Adamo, Barbara; Galván, Patricia; Fernández, Aranzazu; Gaba, Lydia; Díez, Marc; Viladot, Margarita; Arance, Ana; Muñoz, Montserrat Journal: Breast Issue: Volume 24(2015)Supplement 2 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2. (24th January 2019) Authors: Prat, Aleix; Brase, Jan Christoph; Cheng, Yuan; Nuciforo, Paolo; Paré, Laia; Pascual, Tomás; Martínez, Débora; Galván, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, José; Ciruelos, Eva Journal: Oncologist Issue: Volume 24:Number 7(2019) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gene expression profiles of breast cancer metastasis according to organ site. Issue 1 (23rd June 2021) Authors: Brasó‐Maristany, Fara; Paré, Laia; Chic, Nuria; Martínez‐Sáez, Olga; Pascual, Tomás; Mallafré‐Larrosa, Meritxell; Schettini, Francesco; González‐Farré, Blanca; Sanfeliu, Esther; Martínez, Débora; Galván, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa, Pablo; Ciruelos, Eva; Carcelero, Esther... Journal: Molecular oncology Issue: Volume 16:Issue 1(2022) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. (30th April 2019) Authors: Prat, Aleix; Pascual, Tomás; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortés, Javier; Rexer, Brent; Paré, Laia; Forero, Andres; Wolff, Antonio C; Morales, Serafín; Adamo, Barbara; Brasó-Maristany, Fara; Vidal, Maria; Veeraraghavan, Jamunarani; Krop, Ian; Galv... Journal: Journal of the National Cancer Institute Issue: Volume 112:Number 1(2020) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis. (March 2020) Authors: Schettini, Francesco; Pascual, Tomás; Conte, Benedetta; Chic, Nuria; Brasó-Maristany, Fara; Galván, Patricia; Martínez, Olga; Adamo, Barbara; Vidal, Maria; Muñoz, Montserrat; Fernández-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina; Conte, Pier Franco; Locci, Mariavittori... Journal: Cancer treatment reviews Issue: Volume 84(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. (28th December 2022) Authors: Brasó-Maristany, Fara; Griguolo, Gaia; Chic, Nuria; Pascual, Tomás; Paré, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez-Sáez, Olga; Marín-Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal, Maria; Ad... Journal: Journal of the National Cancer Institute Issue: Volume 115:Number 3(2023) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Molecular Characterization of Basal‐Like and Non‐Basal‐Like Triple‐Negative Breast Cancer. (12th February 2013) Authors: Prat, Aleix; Adamo, Barbara; Cheang, Maggie C.U.; Anders, Carey K.; Carey, Lisa A.; Perou, Charles M. Journal: Oncologist Issue: Volume 18:Number 2(2013) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. Issue 1 (December 2015) Authors: Prat, Aleix; Fan, Cheng; Fernández, Aranzazu; Hoadley, Katherine; Martinello, Rossella; Vidal, Maria; Viladot, Margarita; Pineda, Estela; Arance, Ana; Muñoz, Montserrat; Paré, Laia; Cheang, Maggie; Adamo, Barbara; Perou, Charles Journal: BMC medicine Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials. (24th January 2012) Authors: Amos, Keith D.; Adamo, Barbara; Anders, Carey K. Other Names: Chu Quyen D. Academic Editor. Journal: International journal of breast cancer Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗